The modulation of immunity by dendritic cells

Clinical and Applied Immunology Reviews

Volumn 3, Issue 4-5, 2003, Pages 173-182

  Bhardwaj, Nina ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cross presentation; Cytolytic T cells; Dentritic cells; Helper T cells; Immunotherapy

Indexed keywords

CANCER VACCINE; IMMUNOLOGICAL ADJUVANT; INTERCELLULAR ADHESION MOLECULE 3; MANNOSE RECEPTOR; TUMOR ANTIGEN; VIRUS ANTIGEN; VIRUS VACCINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL MIGRATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; IN VIVO STUDY; LYMPHATIC DRAINAGE; MALIGNANT NEOPLASTIC DISEASE; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY; VIRUS INFECTION;

EID: 0141594980     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(02)00159-9     Document Type: Review

References (76)

1. Banchereau J. Briere F. Caux C. Davoust J. Lebeque S. Liu Y.J. Pulendran B. Palucka K. Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767-811
2. Dhodapkar M. Steiman R.M. Sapp M. Desai H. Fossella C. Krasovsky J. Donahoe S.M. Dunbar P.R. Cerundolo V. Nixon D.F. Bhardwaj N. Rapid generation of broad T-cell immunity in humans after single injection of mature dendritic cells J Clin Invest 104 1999 173-180
3. Dhodapkar M.V. Krasovsky J. Steinman R.M. Bhardwaj N. Mature dendritic cells boost functionally superior T cells in humans without foreign helper epitopes J Clin Invest 105 2000 R9-R14
4. Hsu F.J. Benike C. Fagnoni F. Liles T.M. Czerwinski D. Taidi B. Engleman E.G. Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells Nat Med 2 1996 52-58
5. Nestle F.O. Alijagic S. Gilliet M. Sun Y. Grabbe S. Dummer R. Burg G. Schadendorf D. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells Nat Med 4 1998 328-332
6. Murphy G. Tjoa B. Ragde H. Kenny G. Boynton A. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen Prostate 29 1996 371-380
7. Holtl L. Rieser C. Papesh C. Ramoner R. Bartsch G. Thurnher M. CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer Lancet 352 1998 1358
8. Holtl L. Rieser C. Papesh C. Ramoner R. Herold M. Klocker H. Radmayr C. Stenzl A. Bartsch G. Thurnher M. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells J Urol 161 1999 777-782
9. Reichardt V.L. Okada C.Y. Liso A. Benike C.J. Stockerl-Goldstein K.E. Engleman E.G. Blume K.G. Levy R. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: a feasibility study Blood 93 1999 2411-2419
10. Lim S.H. Bailey-Wood R. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma Int J Cancer 83 1999 215-222
11. Morse M.A. Deng Y. Coleman D. Hull S. Kitrell-Fisher E. Nair S. Schlom J. Ryback M.E. Lyerly H.K. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen Clin Cancer Res 5 1999 1331-1338
12. Thurner B. Haendle I. Röder C. Dieckmann D. Keikavoussi P. Jonuleit H. Bender A. Maczek C. Schreiner D. von den Driesch P. Bröcker E.B. Steinman R.M. Enk A. Kämpgen E. Schuler G. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma J Exp Med 190 1999 1669-1678
13. Schuler-Thurner B. Dieckmann D. Keikavoussi P. Bender A. Maczek C. Jonuleit H. Roder C. Haendle I. Leisgang W. Dunbar R. Cerundolo V. von Den Driesch P. Knop J. Brocker E.B. Enk A. Kämpgen E. Schuler G. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells J Immunol 165 2000 3492-3496
14. Thurnher M. Rieser C. Holtl L. Papesh C. Ramoner R. Bartsch G. Dendritic cell-based immunotherapy of renal cell carcinoma Urol Int 61 1998 67-71
15. Panelli M.C. Wunderlich J. Jeffries J. Wang E. Mixon A. Rosenberg S.A. Marincola F.M. Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100 J Immunother 23 2000 487-498
16. Brossart P. Wirths S. Stuhler G. Reichardt V.L. Kanz L. Brugger W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells Blood 96 2000 3102-3108
17. Mackensen A. Herbst B. Chen J.-L. Kohler G. Noppen C. Herr W. Spagnoli G.C. Cerundolo V. Lindemann A. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells Int J Cancer 86 2000 385-392
18. Kugler A. Stuhler G. Walden P. Zoller G. Zobywalski A. Brossart P. Trefzer U. Ullrich S. Muller C.A. Becker V. Gross A.J. Hemmerlein B. Kanz L. Muller G.A. Ringert R.H. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids Nat Med 6 2000 332-336
19. Small E.J. Fratesi P. Reese D.M. Strang G. Laus R. Peshwa M.V. Valone F.H. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells J Clin Oncol 18 2000 3894-3903
20. Tjoa B.A. Erickson S.J. Bowes V.A. Ragde H. Kenny G.M. Cobb O.E. Ireton R.C. Troychak M.J. Boynton A.L. Murphy G.P. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides Prostate 32 1997 272-278
21. Tjoa B.A. Simmons S.J. Bowes V.A. Ragde H. Rogers M. Elgamal A. Kenny G.M. Cobb O.E. Ireton R.C. Troychak M.J. Salgaller M.L. Boynton A.L. Murphy G.P. Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides Prostate 36 1998 39-44
22. Lodge P.A. Jones L.A. Bader R.A. Murphy G.P. Salgaller M.L. Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial Cancer Research 60 2000 829-833
23. Geiger J. Hutchinson R. Hohenkirk L. McKenna E. Chang A. Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells Lancet 356 2000 1163-1165
24. Simons J.W. Mikhak B. Chang J.F. DeMarzo A.M. Carducci M.A. Lim M. Weber C.E. Baccala A.A. Goemann M.A. Slift S.M. Ando D.G. Levitsky H.I. Cohen L.K. Sanda M.G. Mulligan R.C. Partin A.W. Carter H.B. Piantadosi S. Marshall F.F. Nelson W.G. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer Cancer Res 59 1999 5160-5168
25. Colonna M. Krug A. Cella M. Interferon-producing cells: on the front line in immune responses against pathogens Curr Opin Immunol 14 3 2002 373-379
26. Siegal F.P. Kadowaki N. Shodell M. Fitzgerald-Bocarsly P.A. Shah K. Ho S. Antonenko S. Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood Science 284 1999 1835-1837
27. Palucka A.K. Banchereau J. How dendritic cells and microbes interact to elicit or subvert protective immune responses Curr Opin Immunol 14 2002 420-431
28. Askew D. Chu R.S. Krieg A.M. Harding C.V. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms J Immunol 165 2000 6889-6895
29. d'Ostiani C.F. Del Sero G. Bacci A. Montagnoli C. Spreca A. Mencacci A. Ricciardi-Castagnoli P. Romani L. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo J Exp Med 191 2000 1661-1674
30. Cella M. Salio M. Sakakibara Y. Langen H. Julkunen I. Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA J Exp Med 189 1999 821-829
31. Caux C. Massacrier C. Vanbervliet B. Dubois B. Van Kooten C. Durand I. Banchereau J. Activation of human dendritic cells through CD40 cross-linking J Exp Med 180 1994 1263-1272
32. Sauter B. Albert M.L. Francisco L. Larsson M. Somersan S. Bhardwaj N. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J Exp Med 191 2000 423-434
33. Basu S. Binder R. Suto R. Anderson K. Srivastava P. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway Int Immunol 12 2000 1539-1546
34. Sallusto F. Schaerli P. Loetscher P. Schaniel C. Lenig D. Mackay C.R. Qin S. Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation Eur J Immunol 28 1998 2760-2769
35. Sallusto F. Lanzavecchia A. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation J Exp Med 189 1999 611-614
36. Cella M. Engering A. Pinet V. Pieters J. Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells Nature 388 1997 782-787
37. Geijtenbeek T.B.H. Torensma R. van Vliet S.J. van Duijnhoven G.C.F. Adema G.J. van Kooyk Y. Figdor C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses Cell 100 2000 575-585
38. Flores-Romo L. Bjorck P. Duvert V. Van Kooten C. Saeland S. Banchereau J. CD40 ligation on human CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells J Exp Med 185 1997 341-349
39. Turley S.J. Inaba K. Garrett W.S. Ebersold M. Untermaehrer J. Steinman R.M. Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells Science 288 2000 522-527
40. Inaba K. Turley S. Iyoda T. Yamaide F. Shimoyama S. Reise Sousa C. Germain R.N. Mellman I. Steinman R.M. The formation of immunogenic MHC class II- peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli J Exp Med 191 2000 927-936
41. Macatonia S.E. Hosken N.A. Litton M. Vieira P. Hsieh C.-S. Culpepper J.A. Wysocka M. Trinchieri G. Murphy K.M. O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells J Immunol 154 1995 5071-5079
42. Bhardwaj N. Young J.W. Nisanian A.J. Baggers J. Steinman R.M. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses J Exp Med 178 1993 633-642
43. Ridge J.P. Di Rosa F. Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T helper and a T-killer cell Nature 393 1998 474-478
44. Bennett S.R.M. Carbone F.R. Karamalis F. Miller J.J.A.P. Heath W.R. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help J Exp Med 186 1997 65-70
45. Schoenberger S.P. Toes R.E.M. van der Voort E.I.H. Offringa R. Melief C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 393 1998 480-483
46. Zajac A.J. Blattman J.N. Murali-Krishna K. Sourdive D.J.D. Suresh M. Altman J.D. Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function J Exp Med 188 1998 2205-2213
47. + cytolytic T cell responses J Exp Med 182 1995 1663-1671
48. Engelmayer J. Larsson M. Lee M. Cox W.I. Steinman R.M. Bhardwaj N. Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T cell responses from chronically infected individuals J Virol 75 2001 2142-2153
49. Subklewe M. Chahroudi A. Bickham K. Larsson M. Kurilla M.G. Bhardwaj N. Steinman R.M. Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ secreting, T lymphocytes Eur J Immunol 29 1999 3995-4001
50. Larsson M. Fonteneau J.F. Somersan S. Sanders C. Bickham K. Thomas E.K. Mahnke K. Bhardwaj N. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells Eur J Immunol 31 2001 3432-3442
51. Albert M.L. Sauter B. Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86-89
52. Larsson M. Fonteneau J.F. Lirvall M. Haslett P. Lifson J.D. Bhardwaj N. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: Roles for cross-presentation and non-infectious HIV-1 virus AIDS 16 10 2002 1319-1329
53. Dhodapkar M.V. Steinman R.M. Krasovsky J. Munz C. Bhardwaj N. Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells J Exp Med 193 2001 233-238
54. Harshyne L. Watkins S. Gambotto A. Barratt-boyes S. Dendritic cells aquire antigens from live cells for cross-presentation to CTL J Immunol 166 2001 3717-3723
55. Huang A.Y.C. Bruce A.T. Pardoll D.M. Levitsky H.I. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter Immunity 4 1996 349-355
56. Sigal L.J. Crotty S. Andino R. Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen Nature 398 1999 77-80
57. Sigal L.J. Rock K.L. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation J Exp Med 192 2000 1143-1150
58. Lenz L.L. Butz E.A. Bevan M.J. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens J Exp Med 192 2000 1135-1142
59. Neefjes J.J. Stollorz V. Peters P.J. Geuze H.J. Ploegh H.L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route Cell 61 1990 171-183
60. Srivastava P.K. Menoret A. Basu S. Binder R.J. McQuade K.L. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world Immunity 8 1998 657-665
61. Zitvogel L. Regnault A. Lozier A. Wolfers J. Flament C. Tenza D. Ricciardi-Castagnoli P. Raposo G. Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes Nat Med 4 1998 594-600
62. Yrlid U. Wick M.J. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells J Exp Med 191 2000 613-623
63. Bacik I. Snyder H.L. Anton L.C. Russ G. Chen W. Bennink J.R. Urge L. Otvos L. Dudkowska B. Eisenlohr L. Yewdell J.W. Introduction of a Glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatability complex class I- restricted peptides from the endoplasmic reticulum to the cytosol J Exp Med 186 1997 479-487
64. Bronte V. Carroll M.W. Goletz T.J.W. Overwijk W.W. Marincola F. Rosenberg S.A. Moss B. Restifo N.P. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine Proc Natl Acad Sci USA 94 1997 3183-3188
65. Townsend A. Bastin J. Gould K. Brownlee G. Andrews M. Coupar B. Boyle D. Chan S. Smith G. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen J Exp Med 168 1988 1211-1224
66. Ke Y. Kapp J.A. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediator uptake J Exp Med 184 1996 1179-1184
67. Norbury C.C. Hewlett L.J. Prescott A.R. Shastri N. Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages Immunity 3 1995 783-791
68. Regnault A. Lankar D. Lacabanne V. Rodriguez A. Thery C. Rescigno M. Saito T. Verbeek S. Bonnerot C. Ricciardi-Castagnoli P. Amigorena S. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization J Exp Med 189 1999 371-380
69. Heiser A. Dahm P. Yancey D. Maurice M.A. Boczkowski D. Nair S. Gilboa E. Vieweg J. Human dendritic cells transfected with RNA encoding prostate specific antigen (PSA) stimulate prostate specific CTL responses in vitro J Immunol 164 2000 5508-5514
70. Gurunathan S. Klinman D.M. Seder R.A. DNA vaccines: immunology, application, and optimization Annu Rev Immunol 18 2000 927-974
71. Gallucci S. Lolkema M. Matzinger P. Natural adjuvants: endogenous activators of dendritic cells Nat Med 5 1999 1249-1255
72. Geijtenbeek T.B.H. Kwon D.S. Torensma R. van Vliet S.J. van Duijnhoven G.C.F. Middel J. Cornelissen I.L.M.H.A. Nottet H.S.L.M. KewalRamani V.N. Littman D.R. Figdor C.G. van Kooyk Y. DC-SIGN, a dendritic cell specific HIV-1 binding protein that enhances TRANS-infection of T cells Cell 100 2000 587-597
73. Turville S.G. Cameron P.U. Handley A. Lin G. Pohlmann S. Doms R.W. Cunningham A.L. Diversity of receptors binding HIV on dendritic cell subsets Nat Immunol 3 10 2002 975-983
74. Fong L. Engleman E.G. Dendritic cells in cancer immunotherapy Annu Rev Immunol 18 2000 245-273
75. Jonuleit H. Schmitt E. Schuler G. Knop J. Enk A.H. Induction of human IL-10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells J Exp Med 192 2000 1213-1222
76. Mackenson A. Drager R. Schlesier M. Mertelsmann Lindenmann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells Cancer Immunol Immunother 49 2000 152-156